Katz and Kang will present their 9-year outcomes on 515 patients treated by stereotactic body radiation therapy (SBRT) at the Genitourinary Cancers Symposium tomorrow … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: body, CyberKnife, outcome, radiation, SBRT, stereotactic | 6 Comments »
A group of Italian researchers has reported preliminary clinical experience of the use of stereotactic body radiation therapy (SBRT), using CyberKnife technology, in the treatment of isolated, nodal metastases as a consequence of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: CyberKnife, isolated, nodal, radiation, SBRT, stereotactic | 1 Comment »
A recent, retrospective analysis of Medicare data suggests that men who have first-line stereotactic body radiation therapy (SBRT) are at somewhat higher risk for genitourinary (GU) side effects than men who select intensity-moduated radiation therapy (IMRT). … READ MORE …
Filed under: Management, Treatment, Uncategorized | Tagged: body, CyberKnife, IMRT, intensity-modulated, SBRT, sterotactic | 5 Comments »
A paper in the May issue of the journal Radiation Oncology has provided 6-year outcome data (including quality of life and complications of treatment) after the use of stereotactic body radiation therapy (SBRT) using the CyberKnife system (from the Flushing Radiation Oncology group in Flushing, New York). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: body, CyberKnife, localized, outcome, SBRT, stereotactic | 9 Comments »
A new paper in the journal Radiation Oncology provides data on a series of 41 men treated with stereotactic body radiation therapy for intermediate-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: body, CyberKnife, intermediate, radiatio, risk, SBRT, stereotactic | 2 Comments »
Many regular readers may be interested in a blog post by Gary Schwitzer on the MedPage Today web site. It addresses the increasing advertising of CyberKnife radiation therapy (a form of stereotactic body radiation therapy or SBRT) as a first-line treatment for prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: advertising, CyberKnife, promotion, SBRT | 2 Comments »
Data reported by Meier et al. and presented at the recent annual meeting of the American Society for Radiation Oncology (ASTRO) provide some early guidance on the efficacy and safety of sterotactic body radiation therapy (SBRT) in treatment of men with intermediate-risk, localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: body, CyberKnife, intermediate risk, localized, radiation, SBRT, stereotactic | Leave a comment »
Data from a large, retrospective, multi-center study of stereotactic body radiation therapy (SBRT) with CyberKnife technology in the treatment of men with localized prostate cancer were presented on Wednesday afternoon at the annual meeting of the American Society for Radiation Oncology (ASTRO). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: body, CyberKnife, efficacy, outcome, radiation, SBRT, stereotactic, therapy | 1 Comment »
According to a media release from Accuray, Inc., the company has initiated a multi-center, multinational clinical trial in Europe to compare the outcomes of patients with localized prostate cancer treated with CyberKnife stereotactic body radiation therapy (SBRT), da Vinci robot-assisted laparoscopic surgery (RALP), manual laparoscopic surgery (LRP), and conventionally fractionated intensity modulated radiation therapy (IMRT). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: CyberKnife, IMRT, radiation, SBRT, surgery, trial | 3 Comments »
A misleadingly titled op-ed in Forbes magazine this week by two very committed prostate cancer surgeons reflects the sad lack of reality exhibited by some representatives of the clinical treatment community. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: CyberKnife, fact, localized, opinion, RALP | 7 Comments »
Published reports on the safety and efficacy of extreme hypofactionated radiation therapy (stereotactic body radiation therapy or SBRT, a.k.a. CyberKnife radiation therapy) have, to date, come from just a couple of key centers. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: CyberKnife, outcome, SBRT, stereotactic body radiation therapy | 2 Comments »
A multi-institutional “Registry for Prostate Cancer Radiosurgery” (RPCR) was initially set up in July 2010 to track clinical and functional outcomes of men with localized prostate cancer treated with the CyberKnife stereotactic body radiation therapy system (SBRT) at academic and community-based centers throughout the U.S. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: CyberKnife, outcome, registry, stereotactic body radiation therapy | 3 Comments »
Over the past 20 years there has been an explosion in the different ways that we use varied types of external beam radiation therapy for the treatment of localized and locally advanced forms of prostate cancer. Where is the newly diagnosed patient able to find a good, basic introduction? … READ MORE …
Filed under: Management, Treatment | Tagged: 3D-CRT, CyberKnife, EBRT, external beam radiation therapy, IGRT, IMRT, introduction, PBRT, SBRT, TomoTherapy | 2 Comments »
Most published data on the use of stereotactic body radiation therapy (SBRT; CyberKnife radiation therapy) has been based on a total radiation dose of 32 to 38 Gy delivered in a series of four or five sessions — as compared to the delivery of more like 75 to 80 Gy using intensity-modulated radiation (IMRT) and other forms of targeted external beam radiation therapy (EBRT). … READ MORE …
Filed under: Management, Treatment | Tagged: CyberKnife, dose, escalation, outcome, SBRT, stereotactic body radiation therapy | 2 Comments »
In an announcement this morning that will shake up the innovation end of the cancer radiotherapy business, Accuray, Inc. (which makes and markets the CyberKnife system for stereotactic body radiation therapy) has agreed to acquire TomoTherapy, Inc. (which integrates CT imaging with conformal radiation therapy). … READ MORE …
Filed under: Uncategorized | Tagged: Accuray, CyberKnife, radiation therapy, TomoTherapy, Varian | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 